Search

Your search keyword '"Suppli Ulrik C"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Suppli Ulrik C" Remove constraint Author: "Suppli Ulrik C"
77 results on '"Suppli Ulrik C"'

Search Results

1. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

2. Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study

3. Fertility Treatment Resulting in Live Births in Women with Asthma – Associated with Perennial Allergy?

4. Do telemedical interventions improve quality of life in patients with COPD? A systematic review

5. Identification by cluster analysis of patients with asthma and nasal symptoms using the MASK-air® mHealth app

6. Adherence to inhaled corticosteroids and long-acting β2-agonists in asthma: A MASK-air study

7. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

8. Rhinitis associated with asthma is distinct from rhinitis alone: The ARIA‐MeDALL hypothesis

9. The ARIA-MeDALL hypothesis

11. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App

12. Is diet partly responsible for differences in COVID-19 death rates between and within countries?

13. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

14. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

15. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

16. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

17. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

18. COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper

19. Management of anaphylaxis due to COVID-19 vaccines in the elderly

20. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

21. Aligning the good practice mask with the objectives of the European innovation partnership on active and healthy ageing

22. Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness

23. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

24. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

25. Mask 2017: Aria Digitally-Enabled, Integrated, Person-Centred Care For Rhinitis And Asthma Multimorbidity Using Real-World-Evidence

26. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence

28. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

32. Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries

33. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

34. Management of anaphylaxis due to COVID-19 vaccines in the elderly

35. Biomarkers of Clot Activation and Degradation and Risk of Future Major Cardiovascular Events in Acute Exacerbation of COPD:A Cohort Sub-Study in a Randomized Trial Population

36. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy

37. Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies

38. Assessment of the Control of Allergic Rhinitis and Asthma Test (CARAT) using MASK-air

39. ARIA���EAACI statement on asthma and COVID���19 (June 2, 2020)

40. Global mortality and readmission rates following COPD exacerbation-related hospitalisation: a meta-analysis of 65 945 individual patients.

41. Inhaled Corticosteroid Exposure and Risk of Cataract in Patients with Asthma and COPD: A Systematic Review and Meta-Analysis.

42. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report.

43. Adherence to inhaled corticosteroids in relation to quality of life and symptoms of anxiety and depression in asthma.

44. Physical activity, physical capacity and sedentary behavior among asthma patients.

45. Patients' Perspective on Automated Oxygen Administration during Hospitalization for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Qualitative Study Nested in a Randomized Controlled Trial.

46. Management of anaphylaxis due to COVID-19 vaccines in the elderly.

47. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA 2 LEN consensus.

48. Corticosteroid Resistance in Smokers-A Substudy Analysis of the CORTICO-COP Randomised Controlled Trial.

49. Update on Asthma-COPD Overlap (ACO): A Narrative Review.

50. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy.

Catalog

Books, media, physical & digital resources